ImpriMed is a precision medicine startup leveraging AI to personalize cancer treatment, initially for pets and now expanding into human oncology, with a focus on predicting drug responses.

Genome Insight is a precision healthcare solutions company that aims to integrate genomic information into standard patient care by providing whole-genome based precision diagnostics and personalized genomic data for improved patient diagnosis and treatment.